Perturbation of the T cell repertoire in rheumatoid arthritis.
暂无分享,去创建一个
U. Wagner | C. Weyand | J. Goronzy | K. Koetz | J J Goronzy | C M Weyand | U G Wagner | K Koetz | C. Weyand | Kerstin Koetz
[1] B L Levine,et al. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Gray,et al. Mice lacking MHC class II molecules , 1991, Cell.
[3] V. Kouskoff,et al. Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.
[4] J. Sprent,et al. Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo , 1996, Science.
[5] R. Winchester. The molecular basis of susceptibility to rheumatoid arthritis. , 1994, Advances in immunology.
[6] S. Paget,et al. Predominantly T-cell infiltrate in rheumatoid synovial membranes. , 1975, The New England journal of medicine.
[7] R. Jaenisch,et al. β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells , 1990, Nature.
[8] C. Weyand,et al. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. , 1996, The Journal of clinical investigation.
[9] W. O'Fallon,et al. Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. , 1995, Immunity.
[10] J. Goronzy,et al. T cells in rheumatoid arthritis. Paradigms and facts. , 1995, Rheumatic diseases clinics of North America.
[11] B. Rocha,et al. Lymphocyte lifespans: homeostasis, selection and competition. , 1993, Immunology today.
[12] C. Weyand,et al. Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. , 1994, The Journal of clinical investigation.
[13] P. Gregersen,et al. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. , 1996, Journal of immunology.
[14] I. McInnes,et al. The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis , 1996, Nature Medicine.
[15] T. Schnitzer,et al. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. , 1995, Arthritis and rheumatism.
[16] H. Erlich,et al. MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.
[17] C. Weyand,et al. Co‐stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28− T cells , 1997, European journal of immunology.
[18] I. McInnes,et al. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis , 1997, Nature Medicine.
[19] M. Kurosaka,et al. Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium , 1983, The Journal of experimental medicine.
[20] Mark M. Davis,et al. T-cell antigen receptor genes and T-cell recognition , 1988, Nature.
[21] T. Rème,et al. Clonal V alpha 12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients , 1993, The Journal of experimental medicine.
[22] A. Lanzavecchia,et al. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.
[23] D. Schaid,et al. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[24] Recent clinical trials in the rheumatic diseases , 1997, Current opinion in rheumatology.
[25] B. Kotzin,et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. , 1995, Journal of immunology.
[26] E. Matteson,et al. Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody CAMPATH-1H administered by daily subcutaneous injection. , 1995, Arthritis and rheumatism.
[27] B. Fowlkes,et al. Selective events in T cell development. , 1994, Annual review of immunology.
[28] H. Boehmer. Positive selection of lymphocytes , 1994, Cell.
[29] M. Zöller,et al. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] E. Matteson,et al. Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[31] A. Boots,et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[32] A. McLean,et al. In vivo estimates of division and death rates of human T lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] C. Bunce,et al. CD4+ T-cell memory, CD45R subsets and the persistence of antigen--a unifying concept. , 1998, Immunology today.
[34] A S Perelson,et al. T cell repertoires and competitive exclusion. , 1994, Journal of theoretical biology.
[35] W. Ollier,et al. Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis , 1995, Nature Medicine.
[36] F. Emmrich,et al. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. , 1991, Arthritis and rheumatism.
[37] P. Carlson,et al. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. , 1996, Arthritis and rheumatism.
[38] S. Albani,et al. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. , 1996, Immunology today.
[39] C. Mackall,et al. T-cell regeneration: all repertoires are not created equal. , 1997, Immunology today.